Sep 21, 2026 10 0
Uploaded by Lucas Martin
Favorite
Share
More Options
16
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer_Page 1

Open in WPS to view all 16 pages